Fabian Luther

Fabian Luther

Auto-generated profile, based on publicly available information

Fabian Luther

Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 December 2024 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
CBCecilia Bazzini
Cecilia Bazzini
NBNicole L. Bertschi
Nicole L. Bertschi
OSOliver Steck
Oliver Steck
FLFabian Luther
Fabian Luther
SSStefanie Schärli
Stefanie Schärli
CSChristoph Schlapbach
Christoph Schlapbach

1 October 2021 in Journal of Investigative Dermatology
Verified
Journal Article
Open access
PDF file
CBChiara Bazzini
Chiara Bazzini
NBN.L. Bertschi
N.L. Bertschi
OSO. Steck
O. Steck
NBN. Begré
N. Begré
FLF. Luther
F. Luther
CSC. Schlapbach
C. Schlapbach
TH9 cells, also known as pathogenic TH2 cells, are a subset of proinflammatory effector TH cells characterized by high levels of IL-9 expression. They share many properties with conventional TH2 cells but are distinguished by their expression of the transcription factor PPAR-γ, on which they depend for full effector function. PPAR-γ is best known for its role in controlling lipid and glucose metabolism but is increasingly implicated in type 2 inflammation. However, the role of PPAR-γ in TH9 cells remains unclear. Transcriptional profiling of human TH9 cells in presence or absence of the PPAR-γ inhibitor, GW9662, showed strong upregulation of genes involved in cystine transport and redox control of lipid peroxidation. One of the top upregulated genes was SLC7A11, which encodes a cystine/glutamate transporter. Interestingly, we found that the chemical inhibition of SLC7A11 by erastin and cystine starvation in cystine free medium leads to an increase in lipid ROS levels and cell death in TH9 cells but not in conventional TH2 cells. Moreover, PPAR-γ inhibition promotes a further increase in lipid ROS and cell death upon erastin treatment only in TH9 cells, and this effect was not associated with augmented cellular ROS or mitochondrial ROS. Importantly, the anti-oxidant N-acetylcysteine completely rescued the effect of erastin, alone or in combination with GW9662. Erastin and/or GW9662 were also able to selectively deplete the CCR8+CRTh2+ effector memory T cells isolated from allergic contact dermatitis skin biopsies, which share phenotypic and functional features with TH9 cells. These preliminary data suggest that PPAR-y plays a role in protecting pathogenic TH2 cells from unchecked lipid ROS and consecutive cell death. Our findings open up new therapeutic avenues to selectively target pathogenic TH2 cells in the treatment of allergic diseases by leveraging their particular dependency on cystine to prevent cell death from unchecked lipid ROS.

16 August 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
NBNicole L. Bertschi
Nicole L. Bertschi
OSOliver Steck
Oliver Steck
FLFabian Luther
Fabian Luther
CBCecilia Bazzini
Cecilia Bazzini
LMLeonhard von Meyenn
Leonhard von Meyenn
CSChristoph Schlapbach
Christoph Schlapbach
T helper 9 cells (T H 9) are key drivers of allergic tissue inflammation. They are characterized by the expression of type 2 cytokines, such as IL-9 and IL-13, and the peroxisome proliferator-activated receptor gamma (PPAR-γ) transcription factor. However, the functional role of PPAR-γ in human T H 9 cells remains unknown. Here, we demonstrate that PPAR-γ drives activation-induced glycolysis, which, in turn, specifically promotes the expression of IL-9, but not IL-13, in an mTORC1-dependent manner. In vitro and ex vivo experiments on skin samples of allergic contact dermatitis showed that the PPAR-γ-mTORC1-IL-9 pathway was active in T H 9 cells in human skin inflammation. Additionally, we found that tissue glucose levels were dynamically regulated in acute allergic skin inflammation, suggesting that in situ glucose availability is linked to distinct immunological signals in vivo. Furthermore, paracrine IL-9 induced the lactate transporter MCT1 in IL-9R + T H cells, where it increased aerobic glycolysis and proliferative capacity. Taken together, our findings delineate a hitherto unknown relationship between PPAR-γ-dependent glucose metabolism and the pathogenic effector function of human T H 9 cells. Graphical